Overexpression of the High Affinity Choline Transporter in Cortical Regions Affected by Alzheimer's Disease: Evidence from Rapid Autopsy Studies

T. A. Slotkin, Charles Nemeroff, G. Bissette, F. J. Seidler

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Cholinergic deficits in Alzheimer's disease are typically assessed by choline acetyltransferase, the enzyme that synthesizes acetylcholine. However, the determining step in acetylcholine formation is choline uptake via a high affinity transporter in nerve terminal membranes. Evaluating uptake is difficult because regulatory changes in transporter function decay rapidly postmortem. To overcome this problem, brain regions from patients with or without Alzheimer's disease were frozen within 4 h of death and examined for both choline acetyltransferase activity and for binding of [3H]-hemicholinium-3 to the choline transporter. Consistent with the loss of cholinergic projections, cerebral cortical areas exhibited marked decreases in enzyme activity whereas the putamen, a region not involved in Alzheimer's disease, was unaffected. However, [3H]hemicholinium-3 binding was significantly enhanced in the cortical regions. In the frontal cortex, the increase in [3H]hemicholinium-3 binding far exceeded the loss of choline acetyltransferase, indicating transporter overexpression beyond that necessary to offset loss of synaptic terminals. These results suggest that, in Alzheimer's disease, the loss of cholinergic function is not dictated simply by destruction of nerve terminals, but rather involves additional alterations in choline utilization; interventions aimed at increasing the activity of cholinergic neurons may thus accelerate neurodegeneration.

Original languageEnglish
Pages (from-to)696-702
Number of pages7
JournalJournal of Clinical Investigation
Volume94
Issue number2
StatePublished - Aug 1 1994
Externally publishedYes

Fingerprint

Hemicholinium 3
Choline O-Acetyltransferase
Autopsy
Alzheimer Disease
Cholinergic Agents
Choline
Acetylcholine
Cholinergic Neurons
Putamen
Presynaptic Terminals
Frontal Lobe
Enzymes
Membranes
choline transporter
Brain

Keywords

  • Acetylcholine, function in alzheimer's disease
  • Alzheimer's disease
  • Autopsy, rapid, in Alzheimer's disease
  • Choline acetyltransferase, in Alzheimer's disease
  • Choline transporter, in Alzheimer's disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Overexpression of the High Affinity Choline Transporter in Cortical Regions Affected by Alzheimer's Disease : Evidence from Rapid Autopsy Studies. / Slotkin, T. A.; Nemeroff, Charles; Bissette, G.; Seidler, F. J.

In: Journal of Clinical Investigation, Vol. 94, No. 2, 01.08.1994, p. 696-702.

Research output: Contribution to journalArticle

@article{8d71a5f3940f4fb8adfa4df53a3de2fe,
title = "Overexpression of the High Affinity Choline Transporter in Cortical Regions Affected by Alzheimer's Disease: Evidence from Rapid Autopsy Studies",
abstract = "Cholinergic deficits in Alzheimer's disease are typically assessed by choline acetyltransferase, the enzyme that synthesizes acetylcholine. However, the determining step in acetylcholine formation is choline uptake via a high affinity transporter in nerve terminal membranes. Evaluating uptake is difficult because regulatory changes in transporter function decay rapidly postmortem. To overcome this problem, brain regions from patients with or without Alzheimer's disease were frozen within 4 h of death and examined for both choline acetyltransferase activity and for binding of [3H]-hemicholinium-3 to the choline transporter. Consistent with the loss of cholinergic projections, cerebral cortical areas exhibited marked decreases in enzyme activity whereas the putamen, a region not involved in Alzheimer's disease, was unaffected. However, [3H]hemicholinium-3 binding was significantly enhanced in the cortical regions. In the frontal cortex, the increase in [3H]hemicholinium-3 binding far exceeded the loss of choline acetyltransferase, indicating transporter overexpression beyond that necessary to offset loss of synaptic terminals. These results suggest that, in Alzheimer's disease, the loss of cholinergic function is not dictated simply by destruction of nerve terminals, but rather involves additional alterations in choline utilization; interventions aimed at increasing the activity of cholinergic neurons may thus accelerate neurodegeneration.",
keywords = "Acetylcholine, function in alzheimer's disease, Alzheimer's disease, Autopsy, rapid, in Alzheimer's disease, Choline acetyltransferase, in Alzheimer's disease, Choline transporter, in Alzheimer's disease",
author = "Slotkin, {T. A.} and Charles Nemeroff and G. Bissette and Seidler, {F. J.}",
year = "1994",
month = "8",
day = "1",
language = "English",
volume = "94",
pages = "696--702",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Overexpression of the High Affinity Choline Transporter in Cortical Regions Affected by Alzheimer's Disease

T2 - Evidence from Rapid Autopsy Studies

AU - Slotkin, T. A.

AU - Nemeroff, Charles

AU - Bissette, G.

AU - Seidler, F. J.

PY - 1994/8/1

Y1 - 1994/8/1

N2 - Cholinergic deficits in Alzheimer's disease are typically assessed by choline acetyltransferase, the enzyme that synthesizes acetylcholine. However, the determining step in acetylcholine formation is choline uptake via a high affinity transporter in nerve terminal membranes. Evaluating uptake is difficult because regulatory changes in transporter function decay rapidly postmortem. To overcome this problem, brain regions from patients with or without Alzheimer's disease were frozen within 4 h of death and examined for both choline acetyltransferase activity and for binding of [3H]-hemicholinium-3 to the choline transporter. Consistent with the loss of cholinergic projections, cerebral cortical areas exhibited marked decreases in enzyme activity whereas the putamen, a region not involved in Alzheimer's disease, was unaffected. However, [3H]hemicholinium-3 binding was significantly enhanced in the cortical regions. In the frontal cortex, the increase in [3H]hemicholinium-3 binding far exceeded the loss of choline acetyltransferase, indicating transporter overexpression beyond that necessary to offset loss of synaptic terminals. These results suggest that, in Alzheimer's disease, the loss of cholinergic function is not dictated simply by destruction of nerve terminals, but rather involves additional alterations in choline utilization; interventions aimed at increasing the activity of cholinergic neurons may thus accelerate neurodegeneration.

AB - Cholinergic deficits in Alzheimer's disease are typically assessed by choline acetyltransferase, the enzyme that synthesizes acetylcholine. However, the determining step in acetylcholine formation is choline uptake via a high affinity transporter in nerve terminal membranes. Evaluating uptake is difficult because regulatory changes in transporter function decay rapidly postmortem. To overcome this problem, brain regions from patients with or without Alzheimer's disease were frozen within 4 h of death and examined for both choline acetyltransferase activity and for binding of [3H]-hemicholinium-3 to the choline transporter. Consistent with the loss of cholinergic projections, cerebral cortical areas exhibited marked decreases in enzyme activity whereas the putamen, a region not involved in Alzheimer's disease, was unaffected. However, [3H]hemicholinium-3 binding was significantly enhanced in the cortical regions. In the frontal cortex, the increase in [3H]hemicholinium-3 binding far exceeded the loss of choline acetyltransferase, indicating transporter overexpression beyond that necessary to offset loss of synaptic terminals. These results suggest that, in Alzheimer's disease, the loss of cholinergic function is not dictated simply by destruction of nerve terminals, but rather involves additional alterations in choline utilization; interventions aimed at increasing the activity of cholinergic neurons may thus accelerate neurodegeneration.

KW - Acetylcholine, function in alzheimer's disease

KW - Alzheimer's disease

KW - Autopsy, rapid, in Alzheimer's disease

KW - Choline acetyltransferase, in Alzheimer's disease

KW - Choline transporter, in Alzheimer's disease

UR - http://www.scopus.com/inward/record.url?scp=0027964183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027964183&partnerID=8YFLogxK

M3 - Article

C2 - 8040324

AN - SCOPUS:0027964183

VL - 94

SP - 696

EP - 702

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -